Harvard Bioscience, Inc.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $7.2M |
| Depreciation & Amortization | — |
| Depreciation | $1.2M |
| Amortization | $1.8M |
| Stock-Based Compensation | — |
| Net Cash from Operating Activities | $16.5M |
| Investing Activities | |
| Capital Expenditures | — |
| Business Acquisitions | $20.8M |
| Net Cash from Investing Activities | $-22.3M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $9.8M |
| Net Change in Cash | $2.9M |
| Free Cash Flow | — |